Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Early Detection of Cancer | 13 | 2023 | 90 | 3.810 |
Why?
|
| Mass Screening | 14 | 2023 | 263 | 3.280 |
Why?
|
| Lung Neoplasms | 10 | 2023 | 412 | 2.960 |
Why?
|
| Colorectal Neoplasms | 8 | 2023 | 215 | 2.700 |
Why?
|
| Decision Making | 5 | 2022 | 195 | 2.550 |
Why?
|
| Primary Health Care | 9 | 2022 | 227 | 1.920 |
Why?
|
| Internship and Residency | 5 | 2017 | 313 | 1.400 |
Why?
|
| Electronic Health Records | 4 | 2020 | 162 | 1.380 |
Why?
|
| Students, Medical | 3 | 2022 | 131 | 1.190 |
Why?
|
| Access to Information | 2 | 2019 | 13 | 1.180 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2017 | 353 | 1.100 |
Why?
|
| Attitude of Health Personnel | 4 | 2016 | 183 | 1.060 |
Why?
|
| Computer-Assisted Instruction | 4 | 2015 | 23 | 1.020 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 128 | 0.950 |
Why?
|
| Humans | 52 | 2023 | 32005 | 0.930 |
Why?
|
| Internal Medicine | 4 | 2017 | 54 | 0.900 |
Why?
|
| Curriculum | 5 | 2022 | 213 | 0.810 |
Why?
|
| Nursing Staff | 1 | 2022 | 8 | 0.810 |
Why?
|
| Patient Education as Topic | 6 | 2012 | 271 | 0.800 |
Why?
|
| Clinical Clerkship | 1 | 2022 | 42 | 0.790 |
Why?
|
| Caregivers | 2 | 2020 | 114 | 0.780 |
Why?
|
| Internet | 5 | 2019 | 195 | 0.740 |
Why?
|
| Privacy | 1 | 2020 | 10 | 0.720 |
Why?
|
| Steam | 1 | 2020 | 1 | 0.710 |
Why?
|
| Fires | 1 | 2020 | 5 | 0.700 |
Why?
|
| Philosophy | 2 | 2020 | 2 | 0.690 |
Why?
|
| Hospitals | 1 | 2020 | 102 | 0.680 |
Why?
|
| United States | 14 | 2020 | 3939 | 0.680 |
Why?
|
| User-Computer Interface | 2 | 2019 | 51 | 0.650 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 34 | 0.610 |
Why?
|
| Information Dissemination | 2 | 2016 | 52 | 0.600 |
Why?
|
| Science | 1 | 2017 | 8 | 0.600 |
Why?
|
| False Positive Reactions | 1 | 2017 | 29 | 0.600 |
Why?
|
| Health Literacy | 2 | 2015 | 28 | 0.580 |
Why?
|
| Patient Preference | 2 | 2015 | 47 | 0.580 |
Why?
|
| Health Education | 2 | 2015 | 157 | 0.550 |
Why?
|
| Medical Oncology | 1 | 2017 | 86 | 0.540 |
Why?
|
| Laboratories | 1 | 2016 | 15 | 0.530 |
Why?
|
| Historiography | 1 | 2015 | 1 | 0.520 |
Why?
|
| Mathematics | 1 | 2015 | 9 | 0.520 |
Why?
|
| Male | 24 | 2020 | 19165 | 0.510 |
Why?
|
| Alcohol-Related Disorders | 1 | 2015 | 21 | 0.500 |
Why?
|
| Middle Aged | 19 | 2021 | 11817 | 0.500 |
Why?
|
| Physicians | 1 | 2017 | 158 | 0.490 |
Why?
|
| Female | 24 | 2022 | 19959 | 0.490 |
Why?
|
| Prejudice | 2 | 2013 | 50 | 0.470 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 91 | 0.460 |
Why?
|
| Qualitative Research | 3 | 2022 | 167 | 0.460 |
Why?
|
| Prostatic Neoplasms | 3 | 2014 | 471 | 0.440 |
Why?
|
| Awareness | 1 | 2013 | 29 | 0.440 |
Why?
|
| Adult | 14 | 2023 | 9345 | 0.390 |
Why?
|
| Aged | 11 | 2021 | 10301 | 0.360 |
Why?
|
| Colonoscopy | 2 | 2023 | 45 | 0.360 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2020 | 27 | 0.350 |
Why?
|
| Smoking Cessation | 2 | 2023 | 198 | 0.350 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 1531 | 0.330 |
Why?
|
| Telemedicine | 2 | 2020 | 102 | 0.320 |
Why?
|
| Drug Industry | 1 | 2008 | 17 | 0.320 |
Why?
|
| Medically Uninsured | 1 | 2008 | 32 | 0.310 |
Why?
|
| Multimedia | 2 | 2005 | 19 | 0.310 |
Why?
|
| Patient Compliance | 2 | 2007 | 225 | 0.310 |
Why?
|
| Drug Prescriptions | 1 | 2008 | 54 | 0.310 |
Why?
|
| Patient Participation | 2 | 2022 | 82 | 0.300 |
Why?
|
| Academic Medical Centers | 2 | 2022 | 158 | 0.300 |
Why?
|
| Schools, Medical | 2 | 2022 | 43 | 0.300 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2007 | 5 | 0.300 |
Why?
|
| Drug Therapy | 1 | 2007 | 16 | 0.300 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 765 | 0.300 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2007 | 12 | 0.290 |
Why?
|
| Retrospective Studies | 5 | 2020 | 3509 | 0.290 |
Why?
|
| Health Expenditures | 1 | 2007 | 66 | 0.280 |
Why?
|
| Tablets | 2 | 2022 | 11 | 0.280 |
Why?
|
| History, 20th Century | 2 | 2017 | 71 | 0.270 |
Why?
|
| North Carolina | 7 | 2016 | 1514 | 0.270 |
Why?
|
| Population Surveillance | 1 | 2007 | 124 | 0.270 |
Why?
|
| Feasibility Studies | 2 | 2019 | 293 | 0.270 |
Why?
|
| Pilot Projects | 5 | 2017 | 545 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 918 | 0.250 |
Why?
|
| Office Visits | 1 | 2005 | 73 | 0.240 |
Why?
|
| Government Programs | 1 | 2023 | 9 | 0.220 |
Why?
|
| Tobacco Use Cessation | 1 | 2023 | 20 | 0.220 |
Why?
|
| Clinical Competence | 2 | 2016 | 333 | 0.220 |
Why?
|
| Occult Blood | 2 | 2017 | 9 | 0.220 |
Why?
|
| Ambulatory Care Facilities | 3 | 2019 | 83 | 0.210 |
Why?
|
| Program Evaluation | 5 | 2015 | 185 | 0.200 |
Why?
|
| Interviews as Topic | 3 | 2016 | 263 | 0.200 |
Why?
|
| Efficiency, Organizational | 2 | 2016 | 18 | 0.200 |
Why?
|
| Educational Measurement | 2 | 2017 | 123 | 0.190 |
Why?
|
| Focus Groups | 1 | 2022 | 113 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 1428 | 0.190 |
Why?
|
| Depression | 2 | 2022 | 444 | 0.190 |
Why?
|
| Risk Assessment | 2 | 2019 | 1426 | 0.190 |
Why?
|
| Logistic Models | 3 | 2020 | 781 | 0.190 |
Why?
|
| Blood Glucose | 2 | 2020 | 494 | 0.190 |
Why?
|
| Prospective Studies | 4 | 2022 | 2282 | 0.180 |
Why?
|
| Obesity | 3 | 2013 | 1175 | 0.180 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 257 | 0.180 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 78 | 0.180 |
Why?
|
| Research Design | 2 | 2017 | 313 | 0.180 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 160 | 0.180 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2020 | 3 | 0.180 |
Why?
|
| Fibroins | 1 | 2020 | 5 | 0.180 |
Why?
|
| Knowledge | 1 | 2020 | 14 | 0.180 |
Why?
|
| Endocrinology | 1 | 2019 | 2 | 0.180 |
Why?
|
| Thermodynamics | 1 | 2020 | 46 | 0.180 |
Why?
|
| Monitoring, Ambulatory | 1 | 2019 | 10 | 0.170 |
Why?
|
| Influenza, Human | 1 | 2021 | 122 | 0.170 |
Why?
|
| Temperature | 1 | 2020 | 55 | 0.170 |
Why?
|
| Preventive Health Services | 1 | 2020 | 44 | 0.170 |
Why?
|
| History, 21st Century | 2 | 2020 | 59 | 0.170 |
Why?
|
| Risk | 2 | 2017 | 321 | 0.160 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 125 | 0.160 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 217 | 0.160 |
Why?
|
| Disclosure | 1 | 2018 | 31 | 0.160 |
Why?
|
| Electroencephalography | 2 | 2016 | 73 | 0.160 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 181 | 0.160 |
Why?
|
| Drugs, Generic | 2 | 2008 | 15 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2019 | 108 | 0.150 |
Why?
|
| Socioeconomic Factors | 2 | 2011 | 423 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2017 | 64 | 0.150 |
Why?
|
| Patient Selection | 1 | 2019 | 276 | 0.140 |
Why?
|
| Motor Cortex | 1 | 2016 | 12 | 0.140 |
Why?
|
| Time Factors | 3 | 2019 | 2149 | 0.140 |
Why?
|
| Locomotion | 1 | 2016 | 31 | 0.140 |
Why?
|
| Sex Factors | 2 | 2016 | 663 | 0.140 |
Why?
|
| Education, Medical | 1 | 2017 | 69 | 0.140 |
Why?
|
| Choline Kinase | 1 | 2016 | 1 | 0.130 |
Why?
|
| European Continental Ancestry Group | 3 | 2011 | 1166 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2016 | 24 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2016 | 32 | 0.130 |
Why?
|
| Logic | 1 | 2015 | 2 | 0.130 |
Why?
|
| England | 1 | 2015 | 4 | 0.130 |
Why?
|
| Family Practice | 1 | 2015 | 51 | 0.130 |
Why?
|
| Atherosclerosis | 1 | 2021 | 766 | 0.130 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 10 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 166 | 0.120 |
Why?
|
| Health Surveys | 1 | 2015 | 196 | 0.120 |
Why?
|
| Alcoholism | 1 | 2015 | 101 | 0.120 |
Why?
|
| Communication | 1 | 2016 | 142 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 249 | 0.110 |
Why?
|
| Drug Hypersensitivity | 1 | 2013 | 9 | 0.110 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2013 | 14 | 0.110 |
Why?
|
| Semantic Differential | 1 | 2013 | 6 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 1128 | 0.110 |
Why?
|
| Prevalence | 1 | 2016 | 981 | 0.110 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 32 | 0.110 |
Why?
|
| African Americans | 3 | 2011 | 1425 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2013 | 46 | 0.110 |
Why?
|
| Bacteremia | 1 | 2013 | 65 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 297 | 0.110 |
Why?
|
| Social Marketing | 1 | 2012 | 15 | 0.100 |
Why?
|
| Data Collection | 2 | 2020 | 180 | 0.100 |
Why?
|
| Digital Rectal Examination | 2 | 2009 | 10 | 0.100 |
Why?
|
| MP3-Player | 1 | 2011 | 2 | 0.100 |
Why?
|
| Warfarin | 1 | 2011 | 29 | 0.100 |
Why?
|
| Urban Health Services | 1 | 2011 | 10 | 0.100 |
Why?
|
| Community Health Centers | 1 | 2011 | 16 | 0.100 |
Why?
|
| Program Development | 1 | 2011 | 96 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 324 | 0.090 |
Why?
|
| Research | 1 | 2011 | 74 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2012 | 122 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 240 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 3990 | 0.080 |
Why?
|
| Health Promotion | 1 | 2012 | 246 | 0.080 |
Why?
|
| Marketing of Health Services | 1 | 2008 | 6 | 0.080 |
Why?
|
| Masculinity | 1 | 2008 | 4 | 0.080 |
Why?
|
| Drug Costs | 1 | 2008 | 47 | 0.080 |
Why?
|
| Medicaid | 1 | 2008 | 94 | 0.080 |
Why?
|
| Formularies as Topic | 1 | 2007 | 3 | 0.070 |
Why?
|
| Prescription Fees | 1 | 2007 | 6 | 0.070 |
Why?
|
| Cost Sharing | 1 | 2007 | 10 | 0.070 |
Why?
|
| Cost Control | 1 | 2007 | 18 | 0.070 |
Why?
|
| Drug Utilization | 1 | 2007 | 49 | 0.070 |
Why?
|
| Health Behavior | 1 | 2009 | 232 | 0.070 |
Why?
|
| Microcomputers | 1 | 2005 | 6 | 0.060 |
Why?
|
| North America | 1 | 2005 | 32 | 0.060 |
Why?
|
| Attitude to Computers | 1 | 2005 | 16 | 0.060 |
Why?
|
| Australia | 1 | 2005 | 72 | 0.060 |
Why?
|
| Europe | 1 | 2005 | 82 | 0.060 |
Why?
|
| Medical Records | 1 | 2005 | 76 | 0.060 |
Why?
|
| Health Services | 1 | 2005 | 38 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2005 | 76 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 185 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 684 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2005 | 147 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 165 | 0.050 |
Why?
|
| Risk Factors | 2 | 2021 | 3876 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 510 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 39 | 0.050 |
Why?
|
| Infant | 2 | 2016 | 1061 | 0.050 |
Why?
|
| Silk | 1 | 2021 | 2 | 0.050 |
Why?
|
| Needles | 1 | 2021 | 31 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2265 | 0.050 |
Why?
|
| Lung | 1 | 2023 | 249 | 0.050 |
Why?
|
| Food Supply | 1 | 2021 | 67 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2022 | 220 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 148 | 0.050 |
Why?
|
| Poliomyelitis | 1 | 2020 | 4 | 0.040 |
Why?
|
| Drug Storage | 1 | 2020 | 4 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 19 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2020 | 18 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2020 | 79 | 0.040 |
Why?
|
| Educational Status | 2 | 2012 | 179 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 58 | 0.040 |
Why?
|
| Social Environment | 1 | 2020 | 79 | 0.040 |
Why?
|
| Hospitalists | 1 | 1999 | 9 | 0.040 |
Why?
|
| Workload | 1 | 1999 | 40 | 0.040 |
Why?
|
| Animals | 2 | 2021 | 7541 | 0.040 |
Why?
|
| Patients | 1 | 2018 | 46 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 206 | 0.040 |
Why?
|
| Smoking | 1 | 2022 | 497 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 876 | 0.040 |
Why?
|
| Movement | 1 | 2016 | 51 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 43 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2016 | 5 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 12 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 11 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 90 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2015 | 37 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 1595 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 126 | 0.030 |
Why?
|
| Protein Binding | 1 | 2016 | 201 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 193 | 0.030 |
Why?
|
| Mice | 1 | 2021 | 2484 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 38 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 127 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2015 | 84 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 633 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2015 | 178 | 0.030 |
Why?
|
| beta-Lactams | 1 | 2013 | 7 | 0.030 |
Why?
|
| Apoptosis | 1 | 2016 | 360 | 0.030 |
Why?
|
| Empirical Research | 1 | 2013 | 9 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 8 | 0.030 |
Why?
|
| Tetracycline | 1 | 2013 | 13 | 0.030 |
Why?
|
| Fluoroquinolones | 1 | 2013 | 11 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 376 | 0.030 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2013 | 21 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 726 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 604 | 0.030 |
Why?
|
| Culture | 1 | 2013 | 41 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 288 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2015 | 671 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3306 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2011 | 7 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2011 | 22 | 0.020 |
Why?
|
| Mentors | 1 | 2011 | 31 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 185 | 0.020 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2012 | 86 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 608 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 762 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2011 | 122 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 241 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2009 | 61 | 0.020 |
Why?
|
| Attitude | 1 | 2008 | 40 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2008 | 137 | 0.020 |
Why?
|
| Safety | 1 | 2005 | 77 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2009 | 1817 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 2636 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 3539 | 0.010 |
Why?
|
| Bed Occupancy | 1 | 1999 | 1 | 0.010 |
Why?
|
| Hospital Bed Capacity | 1 | 1999 | 5 | 0.010 |
Why?
|
| Benchmarking | 1 | 1999 | 23 | 0.010 |
Why?
|
| Forecasting | 1 | 1999 | 143 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1999 | 175 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1999 | 141 | 0.010 |
Why?
|